SupplementBlepharitis in the United States 2009: A Survey-based Perspective on Prevalence and Treatment
References (26)
- et al.
Meibomian Gland Dysfunction
Surv Ophthalmol
(1996 Mar-Apr) - et al.
Meibomian Gland Dysfunction: A Clinical Scheme for Description, Diagnosis, Classification, and Grading
Ocul Surf
(2003 Jul) - et al.
Meibomian gland function and the tear lipid layer
Ocul Surf
(2003 Jul) - et al.
Classification of chronic blepharitis
Ophthalmol
(1982 Oct) - et al.
Blepharitis
Infect Dis Clin North Am
(1992 Dec) - et al.
Prevalence of dry eye syndrome among US women
Am J Ophthalmol
(2003 Aug) - et al.
Design of Physicians' Health Study II-a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials
Ann Epidemiol
(2000 Feb) - et al.
Dryness symptoms among an unselected clinical population with and without contact lens wear
Cont Lens Anterior Eye
(2006 Mar) Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes
CIAOJ
(1995 Oct)- et al.
Dysfunctional tear syndrome: a Delphi approach to treatment recommendations
Cornea
(2006 Sep)
2007 Report of the Dry Eye Workshop
Ocul Surf
(2007)
Blepharitis and meibomian gland dysfunction
Cited by (194)
3-month post-procedural evaluation of a combined intense pulsed light and photo-biomodulation system in the treatment of meibomian gland dysfunction
2023, Journal Francais d'OphtalmologieMeibomian gland dysfunction and blepharitis: A common and still unsolved ophthalmic problem
2023, Clinics in DermatologyFormulation development and characterization of dual drug loaded hot-melt extruded inserts for better ocular therapeutic outcomes: Sulfacetamide/prednisolone
2023, Journal of Drug Delivery Science and TechnologyIntegrated multi-omics and machine learning approach reveals lipid metabolic biomarkers and signaling in age-related meibomian gland dysfunction
2023, Computational and Structural Biotechnology JournalDiagnosis and Management of Irritated Eyelids
2022, Advances in Ophthalmology and Optometry
This supplement was supported by an educational grant from Inspire Pharmaceuticals, Inc.
Dr. Lemp states that he is a stockholder in Occulogix and Inspire Pharmaceuticals. Inc. He is a consultant to Alcon, Inspire Pharmaceuticals, Inc., Novagali Pharma, Pfizer, Santen, SARcode Corporation, and Tear-Lab Corporation. Dr. Nichols states that she is a consultant to Allergan, Inspire Pharmaceuticals, and Pfizer. She receives research funding from the National Eye Institute, Alcon, Inspire Pharmaceuticals, Inc., Pfizer, and OcuSense, Inc.
Copyright © 2009 Elsevier Inc. All rights reserved.